CVR number 31939186
Industry 86.9010 Other human health activities

NK Care Hjemmepleje ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  9.1% 6.8% 13.0% 9.2% 12.0%  
Credit score (0-100)  28 35 16 26 19  
Credit rating  BB BBB BB BB BB  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  226 1,519 -17.3 -2.0 -10.5  
EBITDA  17.4 -113 -65.0 -2.0 -10.5  
EBIT  17.4 -113 -65.0 -2.0 -10.5  
Pre-tax profit (PTP)  17.4 -113.5 -66.3 -7.3 -10.5  
Net earnings  13.6 -89.4 -51.8 -7.3 -8.2  
Pre-tax profit without non-rec. items  17.4 -114 -66.3 -7.3 -10.5  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  49.9 -39.5 -91.2 -98.5 -107  
Interest-bearing liabilities  759 50.0 100 105 105  
Balance sheet total (assets)  889 397 14.8 14.5 3.3  
Net Debt  537 -236 98.5 93.0 104  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  226 1,519 -17.3 -2.0 -10.5  
Gross profit growth  0.0% 571.5% 0.0% 88.4% -422.7%  
Employees  3 3 1 1 1  
Employee growth %  0.0% 0.0% -66.7% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  889 397 15 14 3  
Balance sheet change%  2,233.7% -55.4% -96.3% -1.9% -77.0%  
Added value  17.4 -113.1 -65.0 -2.0 -10.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  7.7% -7.4% 376.2% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  3.8% -17.1% -23.9% -1.8% -9.4%  
ROI %  4.1% -26.3% -86.6% -2.0% -10.0%  
ROE %  31.5% -40.0% -25.1% -49.8% -91.8%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  5.6% -9.0% -86.1% -87.2% -97.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  3,083.8% 209.0% -151.6% -4,650.0% -994.5%  
Gearing %  1,518.8% -126.7% -109.6% -106.6% -98.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.1% 1.8% 5.2% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.1 0.9 0.1 0.1 0.0  
Current Ratio  1.1 0.9 0.1 0.1 0.0  
Cash and cash equivalent  221.4 286.4 1.5 12.0 1.0  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  49.9 -39.5 -91.2 -98.5 -106.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  6 -38 -65 -2 -10  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  6 -38 -65 -2 -10  
EBIT / employee  6 -38 -65 -2 -10  
Net earnings / employee  5 -30 -52 -7 -8